Results for cad coronary artery disease pathw... translation from Spanish to English

coronary artery atherosclerosis
ateromatosis aortocoronaria

coronary artery operations nos
coronary artery operations nos

c linic a l investigation of medicinal products for the treatment of unstable coronary artery disease
clinical investigation of medicinal products for the treatment of unstable coronary artery disease

¿qué puedo hacer para reducir mi riesgo de enfermedad de las arterias coronarias (coronary artery disease, cad)?
what can i do to lower my risk of cad?

si se someterá a un injerto de derivación coronaria (coronary artery bypas graft, cabg; un tipo de cirugía del corazón), no debe usar la inyección de ketorolac justo antes o justo después de la cirugía.
if you will be undergoing a coronary artery bypass graft (cabg; a type of heart surgery), you should not use ketorolac injection right before or right after the surgery.

transcrocetinate sodium has shown promise of effectiveness in restoring tissue oxygen levels and improving the ability to walk in a clinical trial of patients with peripheral artery disease (pad) in which reduced delivery of oxygen-rich blood to tissues can cause severe leg pain and impair mobility.
transcrocetinate sodium has shown promise of effectiveness in restoring tissue oxygen levels and improving the ability to walk in a clinical trial of patients with peripheral artery disease (pad) in which reduced delivery of oxygen-rich blood to tissues can cause severe leg pain and impair mobility.

cpmp/ich/363/96 (e9) cpmp/ewp/563/95cpmp/ewp/280/96cpmp/ewp/436/97 cpmp/ewp/1401/98 (incollaboration with qwp)documentos conceptuales c linic a l investigation of medicinal products for the treatment of unstable coronary artery disease c linic a l investigation of medicinal products for prophylactic the treatment of peri-and post-operative v e n o u s t h r o m b o -e m b o lic risk c linic a l investigation of medicinal products for the treatment of venous t h r o m b o -e m b o lic d isease c linic a l investigation of medicinal products for prevention and the t r e a t m e n t o f o s t e o p o r o s is in men c linic a l investigation of medicinal products for the treatment of a m y o t r o p h ic lateral sclerosis the evaluation of diagnostic agents
clinical investigation of medicinal products for prophylactic treatment of peri-and post-operative venous thrombo-embolic risk clinical investigation of medicinal products for treatment of venous thrombo-embolic disease clinical investigation of medicinal products for prevention and treatment of osteoporosis in men clinical investigation of medicinal products for treatment of amyotrophic lateral sclerosis the evaluation of diagnostic agentsguidelines clinical investigation of medicinal products in the treatment of schizophrenia ethnic factors in the acceptability of foreign clinical dataadopted in april 1998adopted in april 1998adopted in april 1998adopted in july 1998